These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18653488)

  • 1. Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.
    Borrás-Blasco J; Navarro-Ruiz A; Borrás C; Casterá E
    J Antimicrob Chemother; 2008 Nov; 62(5):879-88. PubMed ID: 18653488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
    De Clercq E
    Int J Antimicrob Agents; 2009 Apr; 33(4):307-20. PubMed ID: 19108994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing issues related to antiretroviral therapy.
    Lesho EP; Gey DC
    Am Fam Physician; 2003 Aug; 68(4):675-86. PubMed ID: 12952384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous reactions to drugs in children.
    Segal AR; Doherty KM; Leggott J; Zlotoff B
    Pediatrics; 2007 Oct; 120(4):e1082-96. PubMed ID: 17908729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging resistance profiles of newly approved antiretroviral drugs.
    Daar ES
    Top HIV Med; 2008; 16(4):110-6. PubMed ID: 18838744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history of antiretrovirals: key discoveries over the past 25 years.
    De Clercq E
    Rev Med Virol; 2009 Sep; 19(5):287-99. PubMed ID: 19714702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral drugs in the treatment of AIDS: what is in the pipeline ?
    Stellbrink HJ
    Eur J Med Res; 2007 Oct; 12(9):483-95. PubMed ID: 17933730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.
    Hughes CA; Robinson L; Tseng A; MacArthur RD
    Expert Opin Pharmacother; 2009 Oct; 10(15):2445-66. PubMed ID: 19678794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common adverse effects of antiretroviral therapy for HIV disease.
    Reust CE
    Am Fam Physician; 2011 Jun; 83(12):1443-51. PubMed ID: 21671545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment of HIV infection: Swedish recommendations 2007.
    Josephson F; Albert J; Flamholc L; Gisslén M; Karlström O; Lindgren SR; Navér L; Sandström E; Svedhem-Johansson V; Svennerholm B; Sönnerborg A
    Scand J Infect Dis; 2007; 39(6-7):486-507. PubMed ID: 17577810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.
    Rotunda A; Hirsch RJ; Scheinfeld N; Weinberg JM
    Acta Derm Venereol; 2003; 83(1):1-9. PubMed ID: 12636014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.
    Todd G
    Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.